Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with mild thrombocytopenia undergoing PCI

被引:0
|
作者
Jiang, C. [1 ]
Zhang, Y. K. [1 ,2 ]
Hu, S. T. [1 ]
Gu, T. S. [1 ]
Zhang, J. K.
Wu, X. [3 ]
Liu, X. [1 ]
Liu, T. [1 ]
Chen, K. Y. [1 ]
机构
[1] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA
[3] Univ Calif Berkeley, Inst Global Hlth Sci, Berkeley, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Impact of Phenoconversion on Risk for Major Adverse Cardiovascular Events in Clopidogrel-Treated Post-PCI Patients
    Rivera, Jean Malave
    Franchi, Francesco
    Ortega-Paz, Luis
    Doan, Thi
    Lopez, Andres
    Thomas, Cameron D.
    Angiolillo, Dominick J.
    Lee, Craig R.
    Cavallari, Larisa H.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 16 - 16
  • [42] Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study
    Meng, Shaoke
    Guo, Lei
    Ye, Zhishuai
    Wang, Junjie
    Ding, Huaiyu
    Wu, Shanshan
    Huang, Rongchong
    CLINICAL INTERVENTIONS IN AGING, 2022, 17 : 331 - 341
  • [43] Efficacy and Adverse Events of Clopidogrel and Ticagrelor in Patients with Cytochrome P450 2C19 Gene Deletion
    Cai, Xiaofang
    Jiang, S. J.
    Chen, Jiana
    Cai, Xiujuan
    Wang, W. L.
    Huang, J. D.
    Zhang, J. H.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 175 - 181
  • [44] Clinical and peri procedural outcomes using reduced dose prasugrel vs standard dose ticagrelor in elderly patients of acute coronary syndrome undergoing PCI
    Nazir, A.
    Vijay, S. K.
    Singh, A. K.
    Tiwari, B. C.
    Afroz, E.
    Jamwal, N.
    Jha, A.
    Singh, R.
    Thandi, P.
    Qutubuddin, Q.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [45] THE INCIDENCE OF ARRHYTHMIAS AND CLINICAL ARRHYTHMIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH TICAGRELOR OR CLOPIDOGREL IN THE PLATO TRIAL
    Scirica, Benjamin M.
    Cannon, Christopher P.
    Emanuelsson, Hakan
    Harrington, Robert A.
    Husted, Steen
    James, Stefan K.
    Katus, Hugo
    Michelson, Eric L.
    Prem, Pais
    Dmitar, Raev
    Spinar, Jindrich
    Steg, Gabriel
    Storey, Robert F.
    Wallentin, Lars
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [46] Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry
    Brener, Sorin J.
    Alapati, Venkatesh
    Benson, Max M.
    Chan, Doris
    Cunn, Gregory
    Khan, Saadat
    Kutkut, Issa
    Narayanan, C. Arun
    O'Laughlin, John P.
    Sacchi, Terrence J.
    JOURNAL OF INVASIVE CARDIOLOGY, 2019, 31 (08): : 235 - 238
  • [47] Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
    Kang, Min Gyu
    Ahn, Jong Hwa
    Kim, Kyehwan
    Koh, Jin-Sin
    Park, Joeng Rang
    Hwang, Seok Jae
    Park, Yongwhi
    Tantry, Udaya S.
    Gurbel, Paul A.
    Hwang, Jin-Yong
    Jeong, Young-Hoon
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] Net Clinical Benefits of Ticagrelor Compared With Clopidogrel in Asian Acute Coronary Syndrome Patients: A Plato Sub-Study
    Kang, Hyun-Jae
    Clare, Robert M.
    Gao, Runlin
    Himmelmann, Anders
    Held, Claes
    Wallentin, Lars
    James, Stefan
    Becker, Richard C.
    CIRCULATION, 2013, 128 (22)
  • [49] Ticagrelor versus clopidogrel in patients with ST-elevation myocardial infarction: postdischarge mild bleeding and its clinical impacts
    Song, Li
    Liu, Chen
    Zhou, Peng
    Zhou, Jinying
    Sheng, Zhaoxue
    Li, Jiannan
    Chen, Runzhen
    Chen, Yi
    Zhao, Hanjun
    Yan, Hongbing
    CORONARY ARTERY DISEASE, 2021, 32 (02) : 164 - 166